| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aa526ab8413daf73be707d2d370b9e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e223dfcf8f6dc4bf11c984b7926a09e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a383803b9987bf5710b5f1a89c46fc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec16044721d13f2435b41e7841a2ccd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a3c6db08db6c6b5071c554dc51ce6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169bae9e299588aced99ced2b86283a9 |
| publicationDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005037247-A2 |
| titleOfInvention |
Oral matrix formulations of doxazosin |
| abstract |
The present invention relates to extended release pharmaceutical compositions of doxazosin. The compositions include doxazosin, a low viscosity release retarding agent and a high viscosity release retarding agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114224855-A |
| priorityDate |
2003-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |